期刊文献+

2008—2010年某院临床主要病原菌分布及耐药性变迁 被引量:9

Distribution and antimicrobial resistance of major clinical pathogens isolated from 2008 to 2010
暂未订购
导出
摘要 目的探讨某院临床近年主要病原菌分布及耐药性,为临床合理用药提供依据。方法收集该院2008年1月—2010年12月分离自门诊及住院患者的病原菌资料,对其构成及耐药性作统计分析。结果共分离病原菌7 008株,其中革兰阴性菌3 961株(56.52%),革兰阳性菌1 582株(22.57%),真菌1 465株(20.91%);居前3位的病原菌依次为白假丝酵母菌(1 015株,15.00%)、铜绿假单胞菌(906株,12.93%)、大肠埃希菌(874株,12.47%)。2008—2010年,金黄色葡萄球菌中耐甲氧西林株总检出率为85.07%(678/797),凝固酶阴性葡萄球菌中耐甲氧西林株总检出率为73.17%(150/205);大肠埃希菌和肺炎克雷伯菌产超广谱β-内酰胺酶株的总检出率分别为64.19%(561/874)、46.31%(301/650)。金黄色葡萄球菌对万古霉素、替考拉宁敏感,对复方磺胺甲口恶唑敏感率(68.42%~74.51%)较高,对其余抗菌药物敏感率均<30%;凝固酶阴性葡萄球菌对万古霉素、替考拉宁敏感;大肠埃希菌和肺炎克雷伯菌对亚胺培南和美罗培南敏感率(95.52%~100.00%)最高,大肠埃希菌对第三代头孢菌素头孢噻肟、头孢曲松、头孢哌酮和氟喹诺酮类环丙沙星、左氧氟沙星敏感率均<30%。3年铜绿假单胞菌对头孢他啶和美罗培南的敏感率均较高,分别为60.31%~85.83%、59.38%~73.23%。结论该院分离的主要病原菌对常用抗菌药物耐药性普遍较高,应加强监控,合理使用抗菌药物,有效预防和控制医院感染的发生。 Objective To investigate the distribution and antimicrobial resistance of pathogens from patients in a hospital , and provide basis for rational use of antimicrobial agents. Methods Data about bacterial strains isolated from inpatients and outpatients in a hospital from January 2008 to December 2010 were collected , distribution and antimicrobial resistance of pathogens were analyzed. Results A total of 7 008 bacterial strains were isolated, 3 961 (56. 52%) isolates were gram-negative bacteria , 1 582 (22. 57%) were gram-positive bacteria, and 1 465 (20. 91%) were fungi; the top three pathogens were Candida albicans (1 015 isolates, 15. 00%) ,Pseudomonas aeruginosa (906 isolates, 12. 93%),Escherichia coli (874 isolates, 12. 47%). Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 85.07%(678/797) of all Staphylococcus aureus, methicillin-resistant eoagulase-neg- ative Staphylococcus (MRCNS) accounted for 73. 17% (150/205) of all CNS; the isolation rate of extended-spec trum β-lactamase ( ESBLS)-producing Escherichia coli and Klebsiella pneumoniae was 64. 19% ( 561/874 ) and 46. 31%(301/650) respectively. Staphylococcus aureus isolates were sensitive to vancomycin and teicoplanin, the resistant rate to sulfamethoxazole/trimethoprim was 68. 42% - 74. 51%, the resistant rate to the other agents were all 〈30 % ; isolates of CNS were sensitive to vancomycin and teicoplanin; Escherichia coli and Klebsiella pneumoniae had highest sensitive rate to imipenem and meropenem (95.52% - 100. 00%), the resistant rate of Escherichia coli to cefotaxime, ceftriaxone, cefoperazone , eiprofloxacin, and levofloxacin were all 〈30%. Pseudomonas aerugi- nosa had relative higher resistant rate to ceftazidime (60. 31% - 85. 830/oo) and meropenem (59. 38% - 73. 23%). Conclusion Antimicrohial resistance of major pathogens isolated from patients in this hospital were generally high. It should pay more attention to the monitoring of multi-drug resistant strains, antimicrobial agents should be used rationally.
机构地区 焦作市人民医院
出处 《中国感染控制杂志》 CAS 2013年第1期54-58,共5页 Chinese Journal of Infection Control
基金 2011年焦作市科技局基金课题(焦科[2011]92-9)
关键词 病原菌 抗菌药物 抗药性 微生物 医院感染 合理用药 pathogen antimicrobial agent drug resistance, microbial healthcare-associated infection rational drug use
  • 相关文献

参考文献7

二级参考文献32

  • 1张绍银.846株金葡菌中耐甲氧西林葡萄球菌的分离结果及耐药性分析[J].实用医学杂志,2005,21(3):257-257. 被引量:4
  • 2朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 3王继东,周丽珍,宫玲玲,糜祖煌,秦玲.铜绿假单胞菌的多重耐药基因研究[J].中华医院感染学杂志,2006,16(3):241-244. 被引量:77
  • 4McGowan JE.Resistance in nonfermenting gram-negativebacteria:multidrug resistance to the maximum[J].Associa-tion for Professionals in Infection Control and Epidemiology,2006,34(suppl.1):S29-S37.
  • 5Clinical and Laboratory Standards Institute.Performancestandards for antimicrobial susceptibility testing;nineteenthinformational supplement[S].Wayne:Clinical and Labora-tory Standards Institute,2010.
  • 6Farrell DJ,Turnidge JD,Bell J,et al.The in vitro evaluationof tigecycline tested against pathogens isolated in eight coun-tries in the Asia-Western Pacific region(2008)[J].J Infect,2010,60(6):440-451.
  • 7Koomanachai P,Bulik CC,Kuti JL,et al.Pharmacodynamicmodeling of intravenous antibiotics against gram-negativebacteria collected in the United States[J].Clinical Therapeu-tics,2010,32(4):766-779.
  • 8Mendes RE,Farrell DJ,Sader HS,et al.Comprehensive as-sessment of tigecycline activity tested against a world widecollection of Acinetobacter spp.(2005-2009)[J].Diag Mi-crobio Infect Dis,2010,68(3):307-311.
  • 9Wang YF and Dowzicky MJ.In vitro activity of tigecyclineand comparators on Acinetobacter spp.isolates collectedfrom patients with bacteremia and MIC change during theTigecycline Evaluation and Surveillance Trial,2004to 2008[J].Diag Microbio Infect Dis,2010,68(1):73-79.
  • 10Vlieghe E,Phoba MF,Tamfun JJM,et al.Antiviotic resist-ance among bacterial pathogens in Central Africa:a review ofthe published literature between 1955and 2008[J].Int J An-timicrob Agent,2009,34(4):295-303.

共引文献217

同被引文献79

  • 1张蓓,尧荣凤,黄卫春,沈立松.儿科院内临床常见细菌耐药性监测[J].中华医院感染学杂志,2006,16(1):91-95. 被引量:13
  • 2杨长顺,刘文恩.MRSA耐药机制与分子生物学检测方法研究新进展[J].中华医院感染学杂志,2007,17(3):356-358. 被引量:73
  • 3Friedman AD. Transcriptional control of granulocyte and mono- cyte development I-J3. Oneogene,2007,26(47) :6816-6828.
  • 4Shimokawa T, Nunomura S, Fujisawa D, et al. Identification of the C/EBPa C-terminal tail residues involved in the protein interac- tion with GABP and their potency in myeloid differentiation of K562 cells E J3. Biochim Biophys Acta, 2013, 1829 ( 11 ) : 1207- 1217.
  • 5Fragliasso V, Chiodo Y, Ferrari-Amorotti G, et al. Phosphoryla- tion of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBP in K562 cells J. J Cell Biochem,2012,113(5) ..1704-1713.
  • 6Gery S, Koeffler HP. Per2 is a C/EBP target gene implicated in myeloid leukemia [J]. Integr Cancer Ther,2009,8(4) :317-320.
  • 7Thoennissen NH, Thoennissen GB, Abbassi S, et al. Transcription factor CCAAT/enhaneer-binding protein alpha and critical circadi- an clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma [J]. Leuk Lymphoma, 2012,53 (8) : 1577-1585.
  • 8Yang MY, Yang WC, Lin PM, et al. Altered expression of circadi- an clock genes in human chronic myeloid leukemia EJ]. J Biol Rhythms,2011,26(2) : 136-148.
  • 9Wagner K, Zhang P, Rosenbauer F, et al. Absence of the tran scription factor CCAAT enhancer binding protein a results in loss of myeloid identity in bcr/abl-indueed malignancy [J]. Proc Natl Acad Sci U S A,2006,103(16) 6338-6343.
  • 10Ferrari-Amorotti G, Mariani SA, Novi C, et al. The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region,not on specificity of the DNA bind- ing domain[J]. J Biol Chem,2010,285(40) 30837-30850.

引证文献9

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部